Published recall report · ImpurityUpdated · 1 yr 2 mo ago
Hikma Pharmaceuticals USA Inc. recall: Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
Current recall status is unverified. FDA does not update drug-enforcement status after publication. Check the latest official information or ask a pharmacist.
What to do
Check the lot number on your pack against this recall and follow the firm's instructions. Do not stop taking a prescribed medicine without talking to a pharmacist or doctor first.
FDA public enforcement report, opens in a new tabWhich products
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
- Producer
- Hikma Pharmaceuticals USA Inc.
- Brand
- LORAZEPAM
K24118
- Dates on pack
- Lot # K24118, exp. date 10/31/2026
More detail
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
In the news
Reporting from news publishers. Follow the official notice for product advice.
No news stories about this recall yet.